Physician profile
Muzaffar Mirza
NPI 1710977939
$7,661.33
in general payments reported to CMS, 2019-2025
8 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,185 · 2020: $17.16 · 2022: $282 · 2023: $1,231 · 2024: $877 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $2,931 · Food and Beverage: $127 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $2,931.00 |
| Food and Beverage | $127.40 |
| Education | $118.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tulsa Dental Products LLC | $4,185.25 | 2019 | |
| Purelife, LLC | $2,615.00 | 2022-2025 | |
| Acteon INC | $536.00 | 2023 | 1 F88013 Et20-D Diamond Endo Tip, 1 F88183 Cap3 Canal Access Tip, 1 F43715 Endo Files #15 21mm 4pk, 1 F88020 Et Bd Endo Tip |
| Hu-Friedy Mfg. Co., LLC | $118.45 | 2025 | |
| Dentsply Sirona INC | $84.55 | 2024 | Tph Spectra Universal Composite Restorative Low Viscosity, Suresmile |
| Biohorizons Implant Systems INC. | $68.33 | 2022-2024 | Biohorizons |
| Straumann USA LLC | $36.59 | 2022 | |
| 3m Company | $17.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muzaffar Mirza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.